<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-31218" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Vitamin B2 (Riboflavin)</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Peechakara</surname>
            <given-names>Basil V.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sina</surname>
            <given-names>Reddog E.</given-names>
          </name>
          <aff>Michigan State University College of Osteopathic Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gupta</surname>
            <given-names>Mohit</given-names>
          </name>
          <aff>Cleveland Clinic Foundation</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Basil Peechakara declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Reddog Sina declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Mohit Gupta declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>1</day>
          <month>2</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-31218.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p content-type="pubmed-excerpt">Riboflavin, also known as vitamin B2, is a water-soluble vitamin that belongs to the vitamin B complex group. Clinicians frequently prescribe riboflavin as part of a combined formulation with other B complex vitamins as a prophylactic supplement to manage and treat vitamin B2 deficiency. Riboflavin deficiency is a rare condition as it is present in various food choices. However, individuals who follow a diet low in meat and milk, which are considered the best sources of riboflavin, and certain specific groups of people, such as pregnant women, children, and athletes, may be more susceptible to this deficiency. Milk and dairy products are rich in riboflavin and vitamin D. Dairy consumption is the primary source of vitamin D in Western diets. This is why riboflavin deficiency is rare among water-soluble vitamins.</p>
        <p>The United States Food and Drug Administration (FDA) approved the ophthalmic formulation of riboflavin 5&#x02019;-phosphate in treating corneal ectasia post-refractive surgery and managing progressive keratoconus. Off-label uses of oral riboflavin include migraine prophylaxis, neonates undergoing phototherapy, and addressing antiretroviral-induced lactic acidosis.&#x000a0;This activity aims to elucidate the mechanism of action, adverse event profile,&#x000a0;pharmacokinetics, administration, and pertinent interactions for interprofessional healthcare team members involved in treating patients with riboflavin deficiency and related conditions.&#x000a0;</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify manifestations of riboflavin deficiency in diverse patient populations, recognizing signs and symptoms associated with this vitamin B2 insufficiency.</p></list-item><list-item><p>Implement timely evaluation and intervention strategies, incorporating evidence-based practices for managing riboflavin deficiency in various clinical scenarios.</p></list-item><list-item><p>Apply riboflavin supplementation judiciously, considering patient-specific factors, dosages, and formulation options to optimize therapeutic outcomes.</p></list-item><list-item><p>Coordinate care for patients with riboflavin deficiency by collaborating with interprofessional healthcare teams, integrating interventions seamlessly into broader healthcare plans, and ensuring continuity of treatment and follow-up.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=31218&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=31218">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-31218.s2" sec-type="Indications">
        <title>Indications</title>
        <p>Riboflavin, also known as vitamin B2, is a water-soluble vitamin that belongs to the vitamin B complex group. Clinicians frequently prescribe riboflavin as part of a combined formulation with other B complex vitamins as a prophylactic supplement to manage and treat vitamin B2 deficiency. Riboflavin deficiency is a rare condition as it is present in various food choices. However, individuals who follow a diet low in meat and milk, which are considered the best sources of riboflavin, and certain specific groups of people, as discussed below, may be more susceptible to this deficiency.<xref ref-type="bibr" rid="article-31218.r1">[1]</xref></p>
        <p>Milk and dairy products are rich in riboflavin and vitamin D. Dairy consumption is the primary source of vitamin D in Western diets. This is why riboflavin deficiency is rare among water-soluble vitamins. However, an increased intake of semi-skimmed milk in developed countries depletes milk's riboflavin content. Although relatively stable, it easily degrades with light exposure. Milk in a glass bottle may contain less riboflavin if exposed to light.</p>
        <p>Grain products possess low natural amounts, but fortification practices ensure that certain bread and cereals have become sources of riboflavin. Therefore,&#x000a0;according to an article&#x000a0;by Morgan KJ et al, high riboflavin levels were found in those who had cereals for breakfast.<xref ref-type="bibr" rid="article-31218.r2">[2]</xref>&#x000a0;Fatty fish are also excellent sources of riboflavin, and certain fruits and vegetables, especially dark green vegetables, contain reasonably high concentrations. Vegetarians with access to various fruits and vegetables can avoid deficiency, although intake may be lower than omnivores, and elderly vegetarians are at a&#x000a0;higher risk.<xref ref-type="bibr" rid="article-31218.r3">[3]</xref></p>
        <p>
<bold>FDA-Approved Indication</bold>
</p>
        <p>The United States Food and Drug Administration (FDA) approved the ophthalmic formulation of riboflavin 5&#x02019;-phosphate in treating corneal ectasia following refractive surgery and managing progressive keratoconus.<xref ref-type="bibr" rid="article-31218.r4">[4]</xref>&#x000a0;</p>
        <p>
<bold>Off-Label Uses</bold>
</p>
        <p>Off-label uses of oral riboflavin include migraine prophylaxis, neonates undergoing phototherapy, and addressing antiretroviral-induced lactic acidosis.<xref ref-type="bibr" rid="article-31218.r5">[5]</xref><xref ref-type="bibr" rid="article-31218.r6">[6]</xref><xref ref-type="bibr" rid="article-31218.r7">[7]</xref><xref ref-type="bibr" rid="article-31218.r8">[8]</xref></p>
        <p>
<bold>Groups of Individuals at a Higher Risk for Low Riboflavin Intake</bold>
</p>
        <p><bold>Pregnant or lactating women and infants:&#x000a0;</bold>Pregnancy demands higher riboflavin intake as it crosses the placenta. Therefore, if&#x000a0;the maternal status is poor during gestation, the infant will likely have riboflavin deficiency. Breast milk riboflavin&#x000a0;concentration&#x000a0;may reflect maternal intake and can be improved by supplementation if maternal intake is low.</p>
        <p><bold>Children:&#x000a0;</bold>Riboflavin deficiency among children is present in many regions of the world where inadequate levels of milk and meat are common in their diets.<xref ref-type="bibr" rid="article-31218.r1">[1]</xref>&#x000a0;Riboflavin deficiency among children in the Western world&#x000a0;is prevalent in&#x000a0;adolescents, especially girls, because of increased metabolic demand.&#x000a0;</p>
        <p><bold>Older individuals:&#x000a0;</bold>With advancing age, an increasing requirement of riboflavin is due to the decreased efficiency of its absorption by the enterocytes.<xref ref-type="bibr" rid="article-31218.r9">[9]</xref></p>
        <p><bold>Athletes:&#x000a0;</bold>Study results suggest&#x000a0;that vigorous exercise may deplete riboflavin due to consuming the nutrients in the metabolic pathways.<xref ref-type="bibr" rid="article-31218.r10">[10]</xref></p>
        <p><bold>Eating disorders:&#x000a0;</bold>Young women with anorexia nervosa or patients with malignancies and malabsorption syndromes, like celiac disease and short bowel syndrome, have been shown to have low riboflavin levels.<xref ref-type="bibr" rid="article-31218.r10">[10]</xref>&#x000a0;Patients&#x000a0;with lactose intolerance are likely to have suboptimal&#x000a0;intake since dairy products are a good source of riboflavin.</p>
        <p><bold>Long-term use of barbiturates:&#x000a0;</bold>Long-term use of phenobarbital, as well as other barbiturates,&#x000a0;can&#x000a0;deplete riboflavin due to oxidation.<xref ref-type="bibr" rid="article-31218.r11">[11]</xref></p>
        <p>
<bold>Prominent Features of Riboflavin Deficiency</bold>
</p>
        <p>Although the clinical features of some vitamin deficiencies are similar and often coexist, the more common signs of riboflavin deficiency include dry, red, fissured, or ulcerated lips, angular cheilitis, dry, atrophic, magenta-red, or blackish tongue, seborrheic dermatitis on the face, hyperpigmentation of the scrotum or vulva, resembling zinc deficiency, conjunctivitis, sore throat, and fatigue.<xref ref-type="bibr" rid="article-31218.r12">[12]</xref><xref ref-type="bibr" rid="article-31218.r13">[13]</xref></p>
      </sec>
      <sec id="article-31218.s3" sec-type="Mechanism of Action">
        <title>Mechanism of Action</title>
        <p>Riboflavin is involved in the metabolism of macronutrients and the production of some other B-complex vitamins. The nutrient&#x000a0;participates in redox reactions in the metabolic pathways through cofactors flavin adenine dinucleotide (FAD) and flavin&#x000a0;mononucleotide (FMN), derived from riboflavin, by acting as electron carriers.<xref ref-type="bibr" rid="article-31218.r14">[14]</xref>&#x000a0;</p>
        <p>Riboflavin plays a principal role in&#x000a0;the electron transport chain.<xref ref-type="bibr" rid="article-31218.r15">[15]</xref>&#x000a0;Inadequate riboflavin intake would be expected to&#x000a0;disturb the intermediate steps of metabolism, with specific functional implications.&#x000a0;The conversion of the amino acid tryptophan to niacin requires FAD. Similarly, converting vitamin B6 (pyridoxine) to the coenzyme pyridoxal 5&#x02019;-phosphate needs FMN.<xref ref-type="bibr" rid="article-31218.r16">[16]</xref>&#x000a0;</p>
        <p>Riboflavin&#x000a0;is also known as an antioxidant because it regenerates glutathione, a free radical scavenger.<xref ref-type="bibr" rid="article-31218.r17">[17]</xref>&#x000a0;Additionally,&#x000a0;riboflavin is involved in growth and&#x000a0;development, especially during fetal life, reproduction, and&#x000a0;lactation.</p>
        <p>
<bold>Pharmacokinetics</bold>
</p>
        <p><bold>Absorption:&#x000a0;</bold>A small amount of riboflavin is present in foods as free riboflavin,&#x000a0;a&#x000a0;majority as its derivative&#x000a0;flavin adenine dinucleotide (FAD), and a smaller amount as flavin mononucleotide (FMN). Intestinal bacteria also produce a small amount of riboflavin.<xref ref-type="bibr" rid="article-31218.r18">[18]</xref>&#x000a0;For the absorption of dietary riboflavin, a prerequisite is converting FAD and FMN to free riboflavin, catalyzed by enzymes called phosphatases in the enterocyte.<xref ref-type="bibr" rid="article-31218.r19">[19]</xref>&#x000a0;</p>
        <p>Absorption occurs predominantly in the small intestine through a carrier-mediated transport process by RFVT3 (riboflavin transporter).<xref ref-type="bibr" rid="article-31218.r20">[20]</xref>&#x000a0;The absorption of riboflavin is increased by food.</p>
        <p><bold>Distribution:&#x000a0;</bold>Riboflavin is&#x000a0;widely distributed between central and peripheral compartments. Riboflavin can cross the blood-brain barrier. RFVT2, encoded by SLC52A2 (solute carrier family 52 member-2), is responsible for&#x000a0;the tissue distribution of riboflavin.<xref ref-type="bibr" rid="article-31218.r21">[21]</xref>&#x000a0;ABCG2 (ATP-binding cassette G2 transporter) is also responsible for transporting&#x000a0;riboflavin into breast milk, CSF, semen, and bile.<xref ref-type="bibr" rid="article-31218.r15">[15]</xref></p>
        <p><bold>Metabolism: </bold>Riboflavin is converted to coenzymes within the cytoplasm of most tissues, including the liver, heart, and kidney. Riboflavin is&#x000a0;metabolized by flavokinase to form FMN, which is&#x000a0;converted to FAD by FMN adenylyltransferase (FMNAT).<xref ref-type="bibr" rid="article-31218.r22">[22]</xref></p>
        <p><bold>Elimination:&#x000a0;</bold>The elimination half-life of riboflavin is approximately&#x000a0;1 h. Riboflavin is primarily excreted unchanged in the urine. Elimination&#x000a0;in bile is &#x0003c;1%.<xref ref-type="bibr" rid="article-31218.r6">[6]</xref></p>
      </sec>
      <sec id="article-31218.s4" sec-type="Administration">
        <title>Administration</title>
        <p>
<bold>Available Dosage Forms and Strengths</bold>
</p>
        <p>Riboflavin is also available as single-ingredient oral tablets of 25 mg, 50 mg, and 100 mg and oral capsules of 400 mg strengths.&#x000a0;Riboflavin is often available in conjugation with other water-soluble multivitamins.&#x000a0;Riboflavin 5&#x02019;-phosphate is available&#x000a0;as a 0.146% ophthalmic solution formulation.<xref ref-type="bibr" rid="article-31218.r4">[4]</xref></p>
        <p>
<bold>Adult Dosage</bold>
</p>
        <p>
<bold>Recommended daily allowance for riboflavin:</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Adults (aged 19 to 70): The dosage for women is 0.9 to 1.1 mg/d, and for men, it is 1.1 to 1.3 mg/d. These values are based on clinical evidence of deficiency in intake of less than 0.6 mg/d. The recommended daily allowance increases from 1.4 to 1.6 mg/d during pregnancy and lactation.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Adolescents (aged 10 to 18): The dosage is 0.9 to 1.3 mg/d.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Children (aged 1 to 9): The dosage is&#x000a0;0.5 to 0.6 mg/d.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Infants (aged 0 to 12 months): The dosage is&#x000a0;0.3 to 0.4 mg/d.<xref ref-type="bibr" rid="article-31218.r15">[15]</xref></p>
          </list-item>
        </list>
        <p>The dose for supplementation is generally 50 to 100 mg daily.<xref ref-type="bibr" rid="article-31218.r23">[23]</xref> Apart from supplementation in deficiency, it is also prescribed in some clinical situations&#x000a0;as follows:&#x000a0;</p>
        <p>
<bold>Corneal Ectasia Following Refractory Surgery and Progressive Keratoconus</bold>
</p>
        <p>Riboflavin is available for topical ophthalmic use as riboflavin 5&#x02019;-phosphate ophthalmic solution (0.146%) and riboflavin 5&#x02019;-phosphate in 20% dextran solution (0.146%).&#x000a0;These ophthalmic formulations are photo enhancers used in corneal collagen cross-linking to manage keratoconus and corneal ectasia after refractive surgery.&#x000a0;Riboflavin-5'-phosphate induces the formation of singlet oxygen, which enables cross-linking. The corneal&#x000a0;cross-linking system (KXL) leads to&#x000a0;rapid&#x000a0;cross-linking between collagen fibers.<xref ref-type="bibr" rid="article-31218.r24">[24]</xref><xref ref-type="bibr" rid="article-31218.r25">[25]</xref><xref ref-type="bibr" rid="article-31218.r26">[26]</xref></p>
        <p>
<bold>
<bold>Migraine Prophylaxis</bold>
</bold>
</p>
        <p>Riboflavin is effective for the prophylaxis of migraines.&#x000a0;The American Academy of Neurology (AAN) and American Headache Society guidelines endorse the use. The usual dose for migraine prophylaxis is 400 mg daily.<xref ref-type="bibr" rid="article-31218.r6">[6]</xref><xref ref-type="bibr" rid="article-31218.r5">[5]</xref></p>
        <p>
<bold>Neonates Undergoing Phototherapy</bold>
</p>
        <p>The management&#x000a0;of hyperbilirubinemia in the neonatal period is often done with phototherapy. However, phototherapy has been shown to degrade riboflavin and cause a deficiency in newborns. A prophylactic daily oral&#x000a0;dose of riboflavin prevents the development of the deficiency.<xref ref-type="bibr" rid="article-31218.r7">[7]</xref></p>
        <p>
<bold>Antiretroviral-Induced Lactic Acidosis</bold>
</p>
        <p>This rare syndrome results from a group of antiretroviral drugs used&#x000a0;to treat&#x000a0;HIV infection called nonnucleoside reverse transcriptase inhibitors (NNRTI). Discontinuation of the drug and treatment with riboflavin causes its reversal.<xref ref-type="bibr" rid="article-31218.r8">[8]</xref></p>
        <p>
<bold>Specific Patient Populations</bold>
</p>
        <p><bold>Hepatic impairment: </bold>No dose adjustment is required.&#x000a0;</p>
        <p><bold>Renal impairment: </bold>No dose adjustment is necessary.<xref ref-type="bibr" rid="article-31218.r27">[27]</xref></p>
        <p><bold>Pregnancy considerations: </bold>Riboflavin requirements increase during pregnancy. Low consumption of&#x000a0;dairy products during pregnancy is associated with riboflavin deficiency.<xref ref-type="bibr" rid="article-31218.r28">[28]</xref>&#x000a0;Riboflavin deficiency&#x000a0;is a possible risk factor for preeclampsia.<xref ref-type="bibr" rid="article-31218.r29">[29]</xref></p>
        <p><bold>Breastfeeding considerations: </bold>Riboflavin requirement is increased during lactation. Maternal deficiency of riboflavin may predispose the infant to riboflavin deficiency.<xref ref-type="bibr" rid="article-31218.r30">[30]</xref>&#x000a0;Dairy products and meat&#x000a0;are required to provide adequate riboflavin for the mother and infant.<xref ref-type="bibr" rid="article-31218.r30">[30]</xref></p>
        <p><bold>Pediatric patients: </bold>Rare inborn errors of metabolism, such as glutaric acidemia type 1 or multiple acyl-coenzyme A (CoA) dehydrogenase deficiencies (MADD),&#x000a0;in which there is a defect in the formation of riboflavin-dependent enzymes, or Brown-Vialetto-Van Laere syndrome, in which there is a defect in&#x000a0;a riboflavin&#x000a0;transporter&#x000a0;may respond to high-dose riboflavin therapy.<xref ref-type="bibr" rid="article-31218.r31">[31]</xref></p>
        <p><bold>Older patients: </bold>Older&#x000a0;patients with acute illness often have&#x000a0;suboptimal riboflavin status, and supplementation with riboflavin and other nutrients is recommended.<xref ref-type="bibr" rid="article-31218.r32">[32]</xref></p>
      </sec>
      <sec id="article-31218.s5" sec-type="Adverse Effects">
        <title>Adverse Effects</title>
        <p>Riboflavin is relatively safe to administer as it has limited water solubility, and enterocytes do not absorb the excess. However, caution is necessary when administering large doses to pregnant women.&#x000a0;Riboflavin may cause benign urine discoloration.</p>
        <p>
<bold>Drug-Drug Interactions</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Tricyclic antidepressants and tetracyclines can&#x000a0;interfere with riboflavin utilization.<xref ref-type="bibr" rid="article-31218.r15">[15]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Chronic alcohol exposure&#x000a0;impairs intestinal absorption and renal reabsorption of riboflavin.<xref ref-type="bibr" rid="article-31218.r33">[33]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-31218.s6" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>No absolute contraindications to riboflavin intake are apparent. In patients with prior hypersensitivity reactions, riboflavin should be avoided due to the risk of anaphylaxis.<xref ref-type="bibr" rid="article-31218.r34">[34]</xref></p>
      </sec>
      <sec id="article-31218.s7" sec-type="Monitoring">
        <title>Monitoring</title>
        <p>Blood levels and urinary excretion are not sensitive markers of riboflavin deficiency, and the preferred method for assessing riboflavin status is stimulation of the FAD-dependent erythrocyte glutathione reductase. The results express an activation coefficient-EGRAC (erythrocyte glutathione reductase activity coefficient) such that the poorer the riboflavin&#x000a0;status, the higher the activation coefficient.<xref ref-type="bibr" rid="article-31218.r9">[9]</xref>&#x000a0;An EGRAC above 1.3 indicates riboflavin deficiency.<xref ref-type="bibr" rid="article-31218.r27">[27]</xref>&#x000a0;The recommendation is to monitor the healing&#x000a0;of epithelial defects&#x000a0;when using&#x000a0;ophthalmic riboflavin formulation.<xref ref-type="bibr" rid="article-31218.r35">[35]</xref></p>
      </sec>
      <sec id="article-31218.s8" sec-type="Toxicity">
        <title>Toxicity</title>
        <p>No observable toxicities with intakes of riboflavin are from food sources many times the recommended daily allowance. Riboflavin has high water solubility and limited absorption. No adverse effects are from high riboflavin intakes from foods or supplements up to 400 mg daily for at least&#x000a0;3 months. The Food and Nutrition Board has not established the upper limit for riboflavin as it has a good safety profile.&#x000a0;High-dose&#x000a0;riboflavin does not cause toxicity&#x000a0;as excess riboflavin is excreted in the urine.<xref ref-type="bibr" rid="article-31218.r36">[36]</xref></p>
      </sec>
      <sec id="article-31218.s9" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The body does not store riboflavin in large amounts; only small reserves exist in the liver, heart, and&#x000a0;kidneys. Most people obtain riboflavin from their diet.&#x000a0;Those on restricted diet plans and many individuals who do not consume&#x000a0;dairy are prone to developing riboflavin deficiency. Other risk factors for riboflavin deficiency include pregnancy, poverty, old age, depression, breastfeeding, phototherapy, and poor cognition. Riboflavin deficiency can present with many clinical features, leading to poor quality of life.</p>
        <p>Given these facts, an interprofessional team approach that includes clinicians, pharmacists, nurses, and dieticians is required to prevent or correct this nutritional deficiency. Pharmacists play a relevant role in patient education. They are often the first-line professionals to see&#x000a0;patients and can also recommend dosing to the prescribing clinician based on the indication. Nutritionists should emphasize the importance of adequate nutrition, exercise, and healthy weight.</p>
        <p>For outpatients, a&#x000a0;dietitian or nurse educator should be consulted to teach patients about rich riboflavin foods.&#x000a0;The nurse also plays a critical role in educating pregnant mothers on the possibility of riboflavin deficiency when breastfeeding and the need to take supplements. Inborn errors of metabolism, such as Brown-Vialetto-Van Laere syndrome, require coordination between pediatricians and clinical geneticists.&#x000a0;</p>
        <p>An ophthalmologist consultation is required to use riboflavin 5&#x02019;-phosphate for keratoconus appropriately. Treatment by nurses&#x000a0;who look after newborns who receive&#x000a0;phototherapy for hyperbilirubinemia should be aware that this treatment can also cause riboflavin breakdown and the need for supplements.</p>
        <p>Most cases of riboflavin deficiency are preventable by a proactive, interprofessional team approach between clinicians, nutritionists, specialists, pharmacists, and dieticians, which can optimize the treatment outcomes related to riboflavin supplementation. This approach can also&#x000a0;decrease healthcare costs and&#x000a0;improve nutrition status.<xref ref-type="bibr" rid="article-31218.r15">[15]</xref><xref ref-type="bibr" rid="article-31218.r37">[37]</xref><xref ref-type="bibr" rid="article-31218.r38">[38]</xref>&#x000a0;Working as an interprofessional team can adequately address the remediation of vitamin B2 deficiencies.</p>
        <p>When treating riboflavin deficiency, the outcomes are good. The majority of symptoms improve within a few weeks or months. However, those who develop neurological abnormalities may have residual deficits that last for an extended period.<xref ref-type="bibr" rid="article-31218.r39">[39]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-31218.s10">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=31218&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=31218">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/31218/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=31218">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-31218.s11">
        <fig id="article-31218.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Seborrheic Dermatitis Contributed by S bhimji, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="seborrhea" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-31218.s12">
        <title>References</title>
        <ref id="article-31218.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oppenheimer</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Bull</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Thurnham</surname>
                <given-names>DI</given-names>
              </name>
            </person-group>
            <article-title>Riboflavin deficiency in Madang infants.</article-title>
            <source>P N G Med J</source>
            <year>1983</year>
            <month>Mar</month>
            <volume>26</volume>
            <issue>1</issue>
            <fpage>17</fpage>
            <page-range>17-20</page-range>
            <pub-id pub-id-type="pmid">6585094</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31218.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morgan</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Zabik</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Leveille</surname>
                <given-names>GA</given-names>
              </name>
            </person-group>
            <article-title>The role of breakfast in nutrient intake of 5- to 12-year-old children.</article-title>
            <source>Am J Clin Nutr</source>
            <year>1981</year>
            <month>Jul</month>
            <volume>34</volume>
            <issue>7</issue>
            <fpage>1418</fpage>
            <page-range>1418-27</page-range>
            <pub-id pub-id-type="pmid">6266245</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31218.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Woo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kwok</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ho</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Sham</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lau</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Nutritional status of elderly Chinese vegetarians.</article-title>
            <source>Age Ageing</source>
            <year>1998</year>
            <month>Jul</month>
            <volume>27</volume>
            <issue>4</issue>
            <fpage>455</fpage>
            <page-range>455-61</page-range>
            <pub-id pub-id-type="pmid">9884002</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31218.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Belin</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Rajpal</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Hafezi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Gomes</surname>
                <given-names>JAP</given-names>
              </name>
              <name>
                <surname>Cochener</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Corneal Cross-Linking: Current USA Status: Report From the Cornea Society.</article-title>
            <source>Cornea</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>37</volume>
            <issue>10</issue>
            <fpage>1218</fpage>
            <page-range>1218-1225</page-range>
            <pub-id pub-id-type="pmid">30067537</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31218.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Holland</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Silberstein</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Freitag</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Dodick</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Argoff</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ashman</surname>
                <given-names>E</given-names>
              </name>
              <collab>Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society</collab>
            </person-group>
            <article-title>Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society.</article-title>
            <source>Neurology</source>
            <year>2012</year>
            <month>Apr</month>
            <day>24</day>
            <volume>78</volume>
            <issue>17</issue>
            <fpage>1346</fpage>
            <page-range>1346-53</page-range>
            <pub-id pub-id-type="pmid">22529203</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31218.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thompson</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Saluja</surname>
                <given-names>HS</given-names>
              </name>
            </person-group>
            <article-title>Prophylaxis of migraine headaches with riboflavin: A systematic review.</article-title>
            <source>J Clin Pharm Ther</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>42</volume>
            <issue>4</issue>
            <fpage>394</fpage>
            <page-range>394-403</page-range>
            <pub-id pub-id-type="pmid">28485121</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31218.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tan</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Chow</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Karim</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Effect of phototherapy on neonatal riboflavin status.</article-title>
            <source>J Pediatr</source>
            <year>1978</year>
            <month>Sep</month>
            <volume>93</volume>
            <issue>3</issue>
            <fpage>494</fpage>
            <page-range>494-7</page-range>
            <pub-id pub-id-type="pmid">690775</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31218.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Posteraro</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Mauriello</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Winter</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Riboflavin treatment of antiretroviral induced lactic acidosis and hepatic steatosis.</article-title>
            <source>Conn Med</source>
            <year>2001</year>
            <month>Jul</month>
            <volume>65</volume>
            <issue>7</issue>
            <fpage>387</fpage>
            <page-range>387-90</page-range>
            <pub-id pub-id-type="pmid">11508132</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31218.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boisvert</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Mendoza</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Casta&#x000f1;eda</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>De Portocarrero</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Solomons</surname>
                <given-names>NW</given-names>
              </name>
              <name>
                <surname>Gershoff</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Russell</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>Riboflavin requirement of healthy elderly humans and its relationship to macronutrient composition of the diet.</article-title>
            <source>J Nutr</source>
            <year>1993</year>
            <month>May</month>
            <volume>123</volume>
            <issue>5</issue>
            <fpage>915</fpage>
            <page-range>915-25</page-range>
            <pub-id pub-id-type="pmid">8487103</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31218.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Belko</surname>
                <given-names>AZ</given-names>
              </name>
              <name>
                <surname>Obarzanek</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Roach</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rotter</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Urban</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Weinberg</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Roe</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Effects of aerobic exercise and weight loss on riboflavin requirements of moderately obese, marginally deficient young women.</article-title>
            <source>Am J Clin Nutr</source>
            <year>1984</year>
            <month>Sep</month>
            <volume>40</volume>
            <issue>3</issue>
            <fpage>553</fpage>
            <page-range>553-61</page-range>
            <pub-id pub-id-type="pmid">6475825</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31218.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Husebye</surname>
                <given-names>ESN</given-names>
              </name>
              <name>
                <surname>Riedel</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bj&#x000f8;rke-Monsen</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Spigset</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Daltveit</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Gilhus</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>Bj&#x000f8;rk</surname>
                <given-names>MH</given-names>
              </name>
            </person-group>
            <article-title>Vitamin B status and association with antiseizure medication in pregnant women with epilepsy.</article-title>
            <source>Epilepsia</source>
            <year>2021</year>
            <month>Dec</month>
            <volume>62</volume>
            <issue>12</issue>
            <fpage>2968</fpage>
            <page-range>2968-2980</page-range>
            <pub-id pub-id-type="pmid">34590314</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31218.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barthelemy</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Chouvet</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Cambazard</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Skin and mucosal manifestations in vitamin deficiency.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1986</year>
            <month>Dec</month>
            <volume>15</volume>
            <issue>6</issue>
            <fpage>1263</fpage>
            <page-range>1263-74</page-range>
            <pub-id pub-id-type="pmid">2948974</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31218.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blanck</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Bowman</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Serdula</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>LK</given-names>
              </name>
              <name>
                <surname>Kohn</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Woodruff</surname>
                <given-names>BA</given-names>
              </name>
              <collab>Bhutanese Refugee Investigation Group</collab>
            </person-group>
            <article-title>Angular stomatitis and riboflavin status among adolescent Bhutanese refugees living in southeastern Nepal.</article-title>
            <source>Am J Clin Nutr</source>
            <year>2002</year>
            <month>Aug</month>
            <volume>76</volume>
            <issue>2</issue>
            <fpage>430</fpage>
            <page-range>430-5</page-range>
            <pub-id pub-id-type="pmid">12145018</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31218.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Prentice</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Bates</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>A biochemical evaluation of the erythrocyte glutathione reductase (EC 1.6.4.2) test for riboflavin status. 1. Rate and specificity of response in acute deficiency.</article-title>
            <source>Br J Nutr</source>
            <year>1981</year>
            <month>Jan</month>
            <volume>45</volume>
            <issue>1</issue>
            <fpage>37</fpage>
            <page-range>37-52</page-range>
            <pub-id pub-id-type="pmid">7470436</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31218.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pinto</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Zempleni</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Riboflavin.</article-title>
            <source>Adv Nutr</source>
            <year>2016</year>
            <month>Sep</month>
            <volume>7</volume>
            <issue>5</issue>
            <fpage>973</fpage>
            <page-range>973-5</page-range>
            <pub-id pub-id-type="pmid">27633112</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31218.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jarrett</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>McNulty</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hughes</surname>
                <given-names>CF</given-names>
              </name>
              <name>
                <surname>Pentieva</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Strain</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>McCann</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>McAnena</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cunningham</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Molloy</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Flynn</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hopkins</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Horigan</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>O'Connor</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Walton</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>McNulty</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Gibney</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Lamers</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ward</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Vitamin B-6 and riboflavin, their metabolic interaction, and relationship with MTHFR genotype in adults aged 18-102 years.</article-title>
            <source>Am J Clin Nutr</source>
            <year>2022</year>
            <month>Dec</month>
            <day>19</day>
            <volume>116</volume>
            <issue>6</issue>
            <fpage>1767</fpage>
            <page-range>1767-1778</page-range>
            <pub-id pub-id-type="pmid">36264281</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31218.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ashoori</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Saedisomeolia</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Riboflavin (vitamin B&#x02082;) and oxidative stress: a review.</article-title>
            <source>Br J Nutr</source>
            <year>2014</year>
            <month>Jun</month>
            <day>14</day>
            <volume>111</volume>
            <issue>11</issue>
            <fpage>1985</fpage>
            <page-range>1985-91</page-range>
            <pub-id pub-id-type="pmid">24650639</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31218.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>IINUMA</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Synthesis of riboflavin by intestinal bacteria.</article-title>
            <source>J Vitaminol (Kyoto)</source>
            <year>1955</year>
            <month>Feb</month>
            <day>10</day>
            <volume>1</volume>
            <issue>2</issue>
            <fpage>6</fpage>
            <page-range>6-13</page-range>
            <pub-id pub-id-type="pmid">13264325</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31218.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Daniel</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Binninger</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Rehner</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Hydrolysis of FMN and FAD by alkaline phosphatase of the intestinal brush-border membrane.</article-title>
            <source>Int J Vitam Nutr Res</source>
            <year>1983</year>
            <volume>53</volume>
            <issue>1</issue>
            <fpage>109</fpage>
            <page-range>109-14</page-range>
            <pub-id pub-id-type="pmid">6853053</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31218.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Yonezawa</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Recent advances in riboflavin transporter RFVT and its genetic disease.</article-title>
            <source>Pharmacol Ther</source>
            <year>2022</year>
            <month>May</month>
            <volume>233</volume>
            <fpage>108023</fpage>
            <pub-id pub-id-type="pmid">34662687</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31218.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cui</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Chai</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Guan</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Systematic analysis of the role of SLC52A2 in multiple human cancers.</article-title>
            <source>Cancer Cell Int</source>
            <year>2022</year>
            <month>Jan</month>
            <day>06</day>
            <volume>22</volume>
            <issue>1</issue>
            <fpage>8</fpage>
            <pub-id pub-id-type="pmid">34991609</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31218.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hirano</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Izumi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yasuniwa</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Shimajiri</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ke-Yong</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Sasagiri</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kusaba</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Matsumoto</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hasegawa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Akimoto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Akashi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kohno</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Involvement of riboflavin kinase expression in cellular sensitivity against cisplatin.</article-title>
            <source>Int J Oncol</source>
            <year>2011</year>
            <month>Apr</month>
            <volume>38</volume>
            <issue>4</issue>
            <fpage>893</fpage>
            <page-range>893-902</page-range>
            <pub-id pub-id-type="pmid">21308351</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31218.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bourgonje</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Otten</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Sadaghian Sadabad</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>von Martels</surname>
                <given-names>JZH</given-names>
              </name>
              <name>
                <surname>Bulthuis</surname>
                <given-names>MLC</given-names>
              </name>
              <name>
                <surname>Faber</surname>
                <given-names>KN</given-names>
              </name>
              <name>
                <surname>van Goor</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Dijkstra</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Harmsen</surname>
                <given-names>HJM</given-names>
              </name>
            </person-group>
            <article-title>The effect of riboflavin supplementation on the systemic redox status in healthy volunteers: A post-hoc analysis of the RIBOGUT trial.</article-title>
            <source>Free Radic Biol Med</source>
            <year>2022</year>
            <month>Sep</month>
            <volume>190</volume>
            <fpage>169</fpage>
            <page-range>169-178</page-range>
            <pub-id pub-id-type="pmid">35973668</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31218.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gore</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Leucci</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Koay</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Kopsachilis</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Nicolae</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Malandrakis</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Anand</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Allan</surname>
                <given-names>BD</given-names>
              </name>
            </person-group>
            <article-title>Accelerated Pulsed High-Fluence Corneal Cross-Linking for Progressive Keratoconus.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2021</year>
            <month>Jan</month>
            <volume>221</volume>
            <fpage>9</fpage>
            <page-range>9-16</page-range>
            <pub-id pub-id-type="pmid">32818448</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31218.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ostacolo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Caruso</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tronino</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Troisi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Laneri</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pacente</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Del Prete</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sacchi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Enhancement of corneal permeation of riboflavin-5'-phosphate through vitamin E TPGS: a promising approach in corneal trans-epithelial cross linking treatment.</article-title>
            <source>Int J Pharm</source>
            <year>2013</year>
            <month>Jan</month>
            <day>20</day>
            <volume>440</volume>
            <issue>2</issue>
            <fpage>148</fpage>
            <page-range>148-53</page-range>
            <pub-id pub-id-type="pmid">23046664</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31218.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Woo</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Iyer</surname>
                <given-names>JV</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hla</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Mehta</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>DT</given-names>
              </name>
            </person-group>
            <article-title>Conventional Versus Accelerated Collagen Cross-Linking for Keratoconus: A Comparison of Visual, Refractive, Topographic and Biomechanical Outcomes.</article-title>
            <source>Open Ophthalmol J</source>
            <year>2017</year>
            <volume>11</volume>
            <fpage>262</fpage>
            <page-range>262-272</page-range>
            <pub-id pub-id-type="pmid">29081866</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31218.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clase</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Ki</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Holden</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>Water-soluble vitamins in people with low glomerular filtration rate or on dialysis: a review.</article-title>
            <source>Semin Dial</source>
            <year>2013</year>
            <season>Sep-Oct</season>
            <volume>26</volume>
            <issue>5</issue>
            <fpage>546</fpage>
            <page-range>546-67</page-range>
            <pub-id pub-id-type="pmid">23859229</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31218.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Higgins</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Bi</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Barraj</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Scrafford</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>Adequacy of total usual micronutrient intakes among pregnant women in the United States by level of dairy consumption, NHANES 2003-2016.</article-title>
            <source>Nutr Health</source>
            <year>2022</year>
            <month>Dec</month>
            <volume>28</volume>
            <issue>4</issue>
            <fpage>621</fpage>
            <page-range>621-631</page-range>
            <pub-id pub-id-type="pmid">35132897</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31218.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wacker</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fr&#x000fc;hauf</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Schulz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chiwora</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Volz</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Becker</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Riboflavin deficiency and preeclampsia.</article-title>
            <source>Obstet Gynecol</source>
            <year>2000</year>
            <month>Jul</month>
            <volume>96</volume>
            <issue>1</issue>
            <fpage>38</fpage>
            <page-range>38-44</page-range>
            <pub-id pub-id-type="pmid">10862839</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31218.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Allen</surname>
                <given-names>LH</given-names>
              </name>
            </person-group>
            <article-title>B vitamins in breast milk: relative importance of maternal status and intake, and effects on infant status and function.</article-title>
            <source>Adv Nutr</source>
            <year>2012</year>
            <month>May</month>
            <day>01</day>
            <volume>3</volume>
            <issue>3</issue>
            <fpage>362</fpage>
            <page-range>362-9</page-range>
            <pub-id pub-id-type="pmid">22585913</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31218.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chaya</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zampoli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gray</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Booth</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Riordan</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ndondo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fieggen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Rusch</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>van der Watt</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Pillay</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>van der Westhuizen</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Menezes</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wilmshurst</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>The First Case of Riboflavin Transporter Deficiency in sub-Saharan Africa.</article-title>
            <source>Semin Pediatr Neurol</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>26</volume>
            <fpage>10</fpage>
            <page-range>10-14</page-range>
            <pub-id pub-id-type="pmid">29961494</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31218.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gariballa</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Forster</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Powers</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Riboflavin status in acutely ill patients and response to dietary supplements.</article-title>
            <source>JPEN J Parenter Enteral Nutr</source>
            <year>2009</year>
            <season>Nov-Dec</season>
            <volume>33</volume>
            <issue>6</issue>
            <fpage>656</fpage>
            <page-range>656-61</page-range>
            <pub-id pub-id-type="pmid">19644132</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31218.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Subramanian</surname>
                <given-names>VS</given-names>
              </name>
              <name>
                <surname>Subramanya</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Ghosal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Said</surname>
                <given-names>HM</given-names>
              </name>
            </person-group>
            <article-title>Chronic alcohol feeding inhibits physiological and molecular parameters of intestinal and renal riboflavin transport.</article-title>
            <source>Am J Physiol Cell Physiol</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>305</volume>
            <issue>5</issue>
            <fpage>C539</fpage>
            <page-range>C539-46</page-range>
            <pub-id pub-id-type="pmid">23804199</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31218.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ou</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Kuo</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Anaphylaxis to riboflavin (vitamin B2).</article-title>
            <source>Ann Allergy Asthma Immunol</source>
            <year>2001</year>
            <month>Nov</month>
            <volume>87</volume>
            <issue>5</issue>
            <fpage>430</fpage>
            <page-range>430-3</page-range>
            <pub-id pub-id-type="pmid">11730188</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31218.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Beckman</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>Epithelium-on Corneal Collagen Cross-Linking with Hypotonic Riboflavin Solution in Progressive Keratoconus.</article-title>
            <source>Clin Ophthalmol</source>
            <year>2021</year>
            <volume>15</volume>
            <fpage>2921</fpage>
            <page-range>2921-2932</page-range>
            <pub-id pub-id-type="pmid">34262252</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31218.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Suwannasom</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kao</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Pru&#x000df;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Georgieva</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>B&#x000e4;umler</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Riboflavin: The Health Benefits of a Forgotten Natural Vitamin.</article-title>
            <source>Int J Mol Sci</source>
            <year>2020</year>
            <month>Jan</month>
            <day>31</day>
            <volume>21</volume>
            <issue>3</issue>
            <pub-id pub-id-type="pmid">32023913</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31218.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kelly</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Batterham</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tapsell</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>A high prevalence of abnormal nutrition parameters found in predialysis end-stage kidney disease: is it a result of uremia or poor eating habits?</article-title>
            <source>J Ren Nutr</source>
            <year>2014</year>
            <month>Sep</month>
            <volume>24</volume>
            <issue>5</issue>
            <fpage>292</fpage>
            <page-range>292-302</page-range>
            <pub-id pub-id-type="pmid">25023456</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31218.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barile</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Giancaspero</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Brizio</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Panebianco</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Indiveri</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Galluccio</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vergani</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Eberini</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Gianazza</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Biosynthesis of flavin cofactors in man: implications in health and disease.</article-title>
            <source>Curr Pharm Des</source>
            <year>2013</year>
            <volume>19</volume>
            <issue>14</issue>
            <fpage>2649</fpage>
            <page-range>2649-75</page-range>
            <pub-id pub-id-type="pmid">23116402</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31218.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dror</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Allen</surname>
                <given-names>LH</given-names>
              </name>
            </person-group>
            <article-title>Dairy product intake in children and adolescents in developed countries: trends, nutritional contribution, and a review of association with health outcomes.</article-title>
            <source>Nutr Rev</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>72</volume>
            <issue>2</issue>
            <fpage>68</fpage>
            <page-range>68-81</page-range>
            <pub-id pub-id-type="pmid">24330063</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
